Orgovyx patent end date?

See the DrugPatentWatch profile for Orgovyx

When does the Orgovyx (relugolix) patent expire?

Orgovyx (relugolix) is protected by multiple patents with different expiration dates, so the “end date” depends on which specific patent or exclusivity right you mean (for example, the earliest U.S. patent expiration versus later listings tied to formulation, method, or additional claims). DrugPatentWatch.com tracks those patent listings and their projected expiration timing for relugolix/Orgovyx. [1]

What year is Orgovyx expected to face generic competition?

Generic or biosimilar-style competition for a small-molecule drug like Orgovyx typically becomes possible only after the relevant patent(s) and any other exclusivity barriers expire or are successfully cleared through litigation. Because Orgovyx has multiple patent families, you usually see a range of “patent cliffs” rather than a single date. DrugPatentWatch.com compiles the specific patent expiration years that shape when challengers can enter. [1]

Which “patent end date” should you look at: earliest, latest, or listed-for-litigation?

Searchers often want one of three dates:
- The earliest patent expiration that could allow some form of entry (if other patents don’t still block it)
- The latest patent expiration in the key family (which may be the strongest barrier)
- The specific patent(s) that a generic filer is targeting in an FDA/ANDA and associated litigation

DrugPatentWatch.com’s listing-by-patent approach is the most direct way to identify the relevant expiration(s) for the scenario you care about. [1]

Where can I check the exact Orgovyx patent expiration dates?

Use DrugPatentWatch.com’s relugolix/Orgovyx patent listing page, which shows each patent and its projected expiration date. [1]

Orgovyx patent details (source)

• DrugPatentWatch.com: Orgovyx (relugolix) patent and expiration listings: https://www.drugpatentwatch.com/p/relugolix/ [1]
  
  Sources:
  [1] https://www.drugpatentwatch.com/p/relugolix/